Search Results 371-380 of 17426 for Oncogene
Oncogene. 2014. Jul; 33(30):3980-91. The processes that control the progression of ductal carcinoma in situ (DCIS) to invasive breast cancer remain poorly ...
... oncogene tyrosine-protein kinase ROS (ROS1-) directed therapy is not indicated as primary therapy * Provided tumor tissue that demonstrates programmed cell ...
Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...
... oncogene, and proto-oncogene B-RAF. Patients who have a single, operable brain metastasis. Patients with significant edema leading to risk of brain ...
Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.
... oncogene. Patients with unknown EGFR and ALK status require test results at screening. ALK and/or EGFR may be assessed locally or at a central laboratory ...
Differential expression of NF1 type I and type II isoforms in sporadic borderline and invasive epithelial ovarian tumors. Oncogene. 1999 Jan 7; 18(1):257-62.
Bats play an important role in many ecosystems around the world. They are a major predator of night-flying insects, including pests that cost farmers ...
mutation, anaplastic lymphoma kinase (ALK) fusion, and c-ros oncogene 1 (ROS1) fusion. 3. Gastric cancer patients with squamous or with positive HER2 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.